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INTERLEUKIN-1 (IL-1) is an inflammatory mediator that
increases Cl– secretion in intestinal epithelial cells. To
identify the signal transduction pathway(s) involved
in IL-1’s action, cells were treated with IL-1 and the
levels  of  cyclooxygenase  (COX)  enzymes,  prosta-
glandin  E2 (PGE2)  and  phospholipase  A2-activating
protein (PLAP), and the activity of phospholipase A2
(PLA2)  were  measured.  IL-1  caused  concentration-
and  time-dependent  increases in the levels  of  PLA2
activity, and/or in the levels of PLAP, COX-2 and PGE2.
The IL-induced increase in PGE2 levels was biphasic,
with the first peak due to the increase in PLAP levels,
and  the  second  peak  due  to  the  increase  in COX-2
levels.  This  increase  in  PGE2 levels  may  provide  a
mechanism  for  acute  and  chronic  inflammation  in
the intestine.
Key  words:  Interleukin-1  receptor,  Cytokines,  Prosta-
glandin E2 production, Epithelial cells, Inflammatory bowel
disease
Introduction
Many cell functions are regulated by members of the
cytokine  receptor  superfamily.  Signaling  by  these
receptors depends upon their association with differ-
ent  second  messengers and  signal  transduction  sys-
tems.  Interleukin-1  (IL-1),  which  is  produced  by
macrophages/monocytes,  plays  a  central  role  in
immune  and  inflammatory  responses,  acts  on  a
variety of cell types, and exhibits multiple biological
activities.  IL-1  signal  follows  binding  to  specific
receptors on the cell surface. Studies have revealed
the  presence of two types  of  IL-1  receptors: T-cell/
fibroblast  type  I  receptor  expressed  on  T  cells,
epithelial  cells and  fibroblasts; and  type II receptor
expressed  on  B  cells,  macrophages  and  myeloid
cells.1–3 Murine and human cDNA for both receptors
have  been  cloned  and  their  amino  acid  sequences
have  been  reported.2,3 The  two  IL-1  receptors  are
transmembrane glycoproteins of the immunoglobulin
(Ig) superfamily organized into three IgG-like extrac-
ellular domains and share 28% amino acid sequence
identity.2
In  the  intestine,  IL-1  has  been  shown  to  be  an
important  inflammatory  mediator  whose  levels  are
increased in inflammatory bowel disease.4,5 Recently,
we  reported  that  IL-1  stimulates  the  synthesis  of
prostaglandin  E2 (PGE2)  in  rabbit  distal  colon,6
partially  through  the  induction  of  synthesis  of  a
phospholipase-A2 activating protein (PLAP). PLAP in
turn  activates  PLA2,  which  causes  an  increase  in
prostanoid synthesis.7,8 The aim of this study was to
investigate whether IL-1 exerts its effects directly on
epithelial  cells  through  binding  to  specific  IL-1
receptor binding sites on epithelial cell membranes,
and  to  identify  the  signal  transduction  system(s)
involved  in  the  mechanism  of  action  of  acute  and
chronic exposure of IL-1 on epithelial cell function.
Materials and methods
Materials
Human recombinant IL-1b was obtained as a gift from
Dr P. Smith and Dr J. Lee at Smith Kline and Beecham
(Philadelphia,  PA).  Acrylamide,  N9 ,N9 -bis-methylene-
acrylamide,  sodium  dodecyl  sulfate  (SDS),  glycine,
bromophenol  blue,  coomassie  blue  R-250,  alkaline
phosphatase conjugated goat anti-rabbit IgG, Immun-
Lite  II  chemiluminescent  protein  detection  system
and PVDF membrane were from Bio-Rad Laboratory
(Melville,  NY).  Hydrocortisone,  insulin,  transferrin
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(Bedford,  MA).  Fluorescein  isothiocyanate  (FITC)
conjugated  goat  anti-rabbit  IgG  was  from  Jackson
ImmunoResearch  Labs  (West  Grove,  PA).  Penicillin
and streptomycin, RPMI, Dulbecco’s Modified Eagle’s
Medium (DMEM), goat serum and Earl’s balanced salt
solution were from Gibco Laboratories (Grand Island,
NY). All  the  other  chemicals  were  from  Sigma  (St.
Louis, MO).
Methods
(1) Primary culture of rabbit colonic epithelial
cells:
Colonocytes  were  prepared  as  described  recently.9
The distal colon was removed and washed in phos-
phate  buffered  saline  (PBS)  containing  penicillin
(100U/ml),  streptomycin  (100 m g/ml),  fungizone
(10 m g/ml) and gentamycin (100 m g/ml). Colonocytes
were  dissociated  by  exposing  the  washed tissue  to
dispase (neutral protease mix, 3 mg/ml) prepared in
DMEM, low glucose containing 10% fetal calf serum,
100U/ml penicillin and 100 m g/ml streptomycin, and
50 m g/ml gentamycin and 5 m g/ml fungizone) for 1 h
at  37°C.  The  mucosal  surface  was  scraped  after
digestion to release cells, which were then recovered
by centrifugation at 800xg for 5 min. Cells were then
placed  onto  plates  containing  mitomycin  growth-
arrested feeder cells (Swiss 3T3 fibroblasts, ATCC no.
CCL  92) in  DMEM  supplemented  by  20%  fetal  calf
serum, hydrocortisone (0.5 m g/ml), and a mixture of
insulin (5 m g/ml), transferrin (5 m g/ml) and selenium
(5 ng/ml)  with  penicillin  (100U/ml),  streptomycin
(100 m g/ml)  and  gentamycin  (40 m g/ml).  Cultures
were selected by differential plating for the epithelial
population at the first two serial passages, making use
of the fact that fibroblasts attach to cell culture plates
very fast while the epithelial cells do not. Epithelial
cells  were  used  only  between  the  third  and  sixth
passages.  At  the  passages  used,  these  cells  were
positive  for  cytokeratin  staining  (epithelial  cell-spe-
cific  marker)  and  negative  for  vimentin  staining
(fibroblast  cell  marker)  as  has  been  shown  pre-
viously.9 Cells  from  different  animals  were  used  to
increase the number, n.
To  prepare cell homogenates, cells were scraped
off  the  culture  flasks  in  homogenization  buffer
consisting  of:  62.5mM  Tris–HCl,  2 mM  Na2-EDTA,
1 mM  PMSF ,  1mM benzamidine, pH 6.8, containing
10 m g/ml each of aprotinin, soybean trypsin inhibitor,
leupeptin  and  antipain.  Cells were homogenized in
2 ml  homogenization  buffer  by  a  Dounce  homoge-
nizer  for  10  strokes  and  then  sonicated  (model
XL2005  sonicator,  Heat  Systems  Inc.,  Farmingdale,
NY) for 10s. The homogenate was then centrifuged at
500xg  for  10min  to  remove  cell  debris,  and  the
resulting supernatant was used for samples to run on
the polyacrylamide gels.
(2) Polyacrylamide gel electrophoresis and Western
blot analysis:
Polyacrylamide  gel  electrophoresis  was  performed
according  to  Laemmli10 in  a  module Mini-Protein  II
electrophoresis  system  (Bio-Rad  laboratories).  Sam-
ples  (10 m g  each)  were  loaded  on  12%  SDS-poly-
acrylamide gel. Proteins were separated (using con-
stant  voltage  of  200V)  for  45min  and  then
transferred  to  a  PVDF  membrane  using  the  mini
Trans-Blot electrophoretic transfer cell (Bio-Rad Lab-
oratories,  100V  and  250mA  for  1 h).  Following
transfer,  the  membrane  was  washed  in  Tris-buffer
saline  (TBS),  then  incubated  with  5%  non-fat  dry
milk in TBS for 1 h at room temperature followed by
another washing with TBS containing 0.5% Tween-20
(TTBS). The membrane was incubated with the first
antibody  (anti-IL-1  receptor  antibodies:  sheep  anti-
human IL-1R type I-R3 was a generous gift from Dr
J.  E.  Sims,  Immunex  Corporation,  Seattle,  WA;  or
antimelittin  antibodies  for  the  detection  of  PLAP
which  were  a  generous  gift  from  Dr  J.  Bomalaski,
Medical  College  of  Pennsylvania,  PA;  or  with
cyclooxygenase  (COX)-polyclonal  anti  PGHS  pur-
chased from Accurate, Westbury, NY) at  1:500 dilu-
tion  in  1%  non-fat  dry  milk  in  TBS  for  16h.  The
membrane  was  washed  with TTBS,  then  incubated
with alkaline phosphatase conjugated goat-anti-rabbit
IgG  for  2h. The membrane was washed  with TTBS
again, and incubated with the enhancer (Immun-lite,
Bio Rad Laboratories) for 30min. The Immun-Lite II
chemiluminescent  detection  system  was  used  to
detect the immunoreaction bands on the membrane.
A  PhosphorImager  SF  Scanning  system  and  Image-
Quant  software  (Molecular  Dynamics,  Sunnyvale,
CA)  were  used  for  the  scanning  and  estimation  of
each  band  density.
(3) Flow cytometry:
Samples  containing  at  least  13 106 cells  were  incu-
bated  on  ice  for  60min  with  50 m l  rabbit  gamma
globulin (Sigma, St. Louis, MO) at 10mg/ml to block
Fc receptor binding, and 100 m l of a 1/100 dilution of
either normal sheep serum (Jackson Immunoresearch
laboratories Inc., Westgrove, PA) or sheep anti-human
IL-1 receptor type I serum (Immunex). Samples were
washed twice with PBS containing 0.1% bovine serum
albumen and 0.1% NaN3 (PBSA), and then incubated
on  ice  for  30min  with  a  1/50  dilution  of  FITC-
conjugated  donkey  anti-sheep  IgG  (heavy  and  light
chains) (Jackson Immunoresearch Labs Inc.) that had
been  absorbed  to  remove  activity  to  rabbit  serum
proteins. The samples were washed three times in PBS
and resuspended in PBS containing 2% paraformalde-
hyde  for  analysis  on  a  Becton  Dickinson  FACSCAN
using the Consort  30 software.  Live gates were set
based on forward scatter profiles. The Kolmogorov–
Smirnov Test was used to determine the significance
of a shift in fluorescent intensity of IEC stained with
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and live cells was performed by the two-color analysis
using  FITC  and  propidium  iodide  (PI).  Dead  cells
were gated out with PI.
(4) Measurement of total PLA2, secretory PLA2 and
cytoplasmic PLA2 activities:
Purified porcine pancreatic PLA2 (ICN Biochemicals,
Cleveland,  OH)  was  used  as  a  standard. The super-
natant was removed from the cells and homogeniza-
tion  buffer (containing 62.5mM Tris–HCl,  10m g/ml
aprotinin,  10 m g/ml  soybean  trypsin  inhibitor,
10 m g/ml  leupeptin,  10m g/ml  pepstatin  A,  12mM
benzamidine, 1 mM PMSF and 10 m g/ml antipain) was
added. The  cells  were  homogenized  using  Dounce
homogenizer for 10 strokes then sonicated for 10s.
Assays for measuring PLA2 activity  were done using
the  PLA2 assay  kits  from  Cayman  Chemical  (Ann
Arbor, MI). The assay uses the thio ester derivative of
the appropriate substrate for the specific PLA2 type to
be measured. Upon hydrolysis of the thio ester bond
at the sn-2 position by PLA2, free thiols are detected
using 5,59 -dithiobis(2-nitrobenzoic acid).
(5) Measurement of PGE2 levels:
Cells were incubated with IL-1b (10ng/ml) for 30min
in  culture  medium.  Aliquots  from  the  supernatant
were transferred to Eppendorf tubes and centrifuged
at  4°C,  for  2 min  at  9000rpm  in  the  Eppendorf
centrifuge.  Samples  were  kept  at  –  70°C  for  later
determination of PGE2 levels using radioimmunoassay
(RIA).  Commercially  available  RIA  kits  for  measure-
ment of PGE2 were used (Advanced Magnetics Inc.,
MA). The assay involved incubating the sample with
the  corresponding  antiserum  overnight  at  4°C  and
then  centrifuging for 15min  at  4°C at  1000xg. The
supernatant was then transferred to scintillation vials,
and  scintillant  added  and  vial  counted  in  a  liquid
scintillation counter.
Results
Identification of the IL-1 receptor protein on
epithelial cells
For the epithelial cells to be directly regulated by IL-1,
the  receptor  for  IL-1 has to  be present  on  the  cell
membranes.  Using Western  blot  analysis,  we  were
able to show that IL-1 receptor is indeed present in
normal  unstimulated  epithelial  cells  (Fig.  1).  The
receptor identified had an apparent molecular weight
at  80kD,  consistent  with  the  IL-1R  type  I.  Using
similar methodology, IL-1R type II (Sheep anti-human
IL-1R type II was a generous gift from Immunex) was
not  present  on  these  epithelial  cells  (data  not
shown).
Flow  cytometry  experiments  were  also  per-
formed to further prove the presence of the recep-
tor  on  the  isolated  epithelial  cells.  Forward  scatter
of  epithelial  cells  revealed  the  presence  of  one
population of cells based on size. Cells were treated
with  either  immune  serum  (antibodies  obtained  as
a  gift  from Immunex as listed in  Materials) or non-
immune  serum  (controls). They  showed  a  shift  in
fluorescence  (Fig.  2)  which  was  significant  (total
number of experiments=4; P<0.001), indicating the
presence  of  the  receptor  on  the  epithelial  cells.
Similar experiments were repeated using antibodies
to IL-1R type II (Sheep anti-human IL-1R type II was
a  generous  gift  from  Immunex).  No  IL-1R  type  II
was  present  on  the  epithelial  cells  (data  not
shown).
IL-1 action and mechanism in epithelial cells
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FIG. 1. A representative Western blot (one of three experi-
ments) showing the presence of the IL-1 receptor type I (size,
80kD) in the cultured colonic epithelial cells (lane a). Lane b
shows the presence of the IL-1 receptor in human monocytes
as a positive control.
FIG.  2.  Single-parameter fluorescence histograms  (one  of
three experiments) of: (A) unstained cells, (B) cells stained
with  non-immune  serum,  and  (C)  cells  stained  with  anti-
bodies against IL-1R type I. There was a significant shift in
fluorescence (P<0.001), indicating the presence of the recep-
tor on the epithelial cells.Using Western blotting assays, we tested whether
long exposure of IL-1 regulates the levels of IL-1R. The
levels of IL-1 receptor were not changed by treatment
by IL-1 for up to 24h (Fig. 3).
PLAP levels in epithelial cells
Intestinal epithelial cells were incubated with IL-1b at
different  concentrations and  for  different  time peri-
ods, and the levels of PLAP measured using Western
blotting  assays.  PLAP  levels  were  significantly
increased when cells were treated with IL-1b to reach
maximal  levels  between  10  and  30min  with  IL-1b
concentration of 30ng/ml (Fig. 4). PLAP levels went
back  to  baseline  levels  afterwards  and  stayed  there
even 24h post-treatment with IL-1b .
Activity of PLA2 in epithelial cells
Epithelial cells were incubated with different concen-
trations of IL-1b for different lengths of time, and the
activity  of  secretory  (sPLA2),  cytoplasmic  PLA2
(cPLA2)  and  total  PLA2 enzymes  measured.  sPLA2
F. R. Homaidan et al.
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FIG. 3. Levels of IL-1 receptor, type I, in rabbit colonocytes
treated with IL-1  (30ng/ml)  for  different  time  periods. No
significant increase in the receptor levels was observed at
any of the times tested. Data are means±SE for four separate
experiments.
FIG. 4. (A) A representative Western blot (one of four experiments) showing the presence of PLAP (size, 42kD) and its induction
in cells treated with IL-1 (10ng/ml) for different time periods. Lane a, 0min; lane b, 2min; lane c, 10min; lane d, 30min; lane
e, 1h; lane f, 12h; and laneg, 24h. (B) Levels of PLAP in cells treated with IL-1 (10ng/ml) for different time periods. (C) Levels
of PLAP in cells treated with different concentrations of IL-1 for 10min. * P<0.05, ** P<0.005; P value represents the comparison
of the effect of IL-1 on PLAP levels as compared with untreated control. Data are means±SE for four separate experiments.IL-1 action and mechanism in epithelial cells
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activity were increased significantly with IL-1b treat-
ment  and  reached  a  peak  of  activity  of  around
10nmol/min/mg protein  30min after IL-1b addition
at a concentration of 30ng/ml (Fig. 5). This increase
correlated  well  with  the  increase  observed  in  IL-
1-induced  PLAP  levels.  sPLA2 levels  went  back  to
baseline levels and stayed at control levels 24h after
IL-1b treatment. The activity of cPLA2 did not change
by  IL-1  treatment  over  the  time  course  or  the
concentration range studied, as shown in Fig. 5.
Levels of COX-1 and COX-2 in epithelial cells
To  test  whether  IL-1  had  any  effect  on  the  COX
pathway,  COX-1  and  COX-2  protein  levels  were
measured at different IL-1b concentrations and differ-
ent times. IL-1 had no effect on COX-1 protein levels
(data not shown). However, COX-2, which was not
present in the intestinal epithelial cells under control
conditions (Fig. 6), was significantly induced by IL-1b
treatment.  It  reached peak  levels 6h post-treatment
and was back to almost undetectable levels in around
24h.
Production of PGE2 by epithelial cells and
regulation by IL-1b
Treatment of epithelial cells for long times with IL-1b
causes a biphasic increase in the levels of PGE2 (Fig.
7). The  first  peak  that  was  observed  30min  after
addition of IL-1b correlated well with the increase in
PLAP levels as already seen and published earlier.7,8
The second peak appeared 6 h after the addition of IL-
1b ,  correlating  well  with  the  increase  observed  in
FIG. 5. Activity of total (d ), secretory (s ), and cytoplasmic PLA2 (m ): (A) in cells treated with IL-1 (10ng/ml) for different time
periods, and (B) in cells treated with different concentrations of IL-1 for 10min. * P<0.05, ** P<0.005; P value represents the
comparison of the effect of IL-1 on PLA2 levels as compared with untreated control. Data are means±SE for six separate
experiments.FIG. 6. (A) A representative Western blot (one of three experiments) showing induction of COX-2 (size, 70kD) protein synthesis
by IL-1b for different time periods as follows: lane a, 0min; lane b, 30min; lane c, 1h; lane d, 2h; lane e, 4h; lane f, 6h; laneg,
8h; laneh, 12h; and lane i, 24h. (B) Levels of COX-2 in cells treated with IL-1b (10ng/ml) for 24h. * P<0.05, ** P<0.005; P value
represents the comparison of the effect of IL-1b on COX-2 levels as compared with untreated control. Data are means±SE for
three separate experiments.
FIG. 7. Levels of PGE2 in (d ) cells treated with IL-1b (10ng/ml) as compared with (j ) control untreated cells, with (s ) cells
treated with the IL-1ra and with (m ) cells treated with IL-1b and IL-1ra together. * P<0.05, ** P<0.005; P value represents the
comparison of the treatment on PGE2 production as compared with untreated time control. Data are means±SE for six separate
experiments.
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completely  abolished  when  cells  were  pretreated
with  IL-1  receptor  antagonist  (IL-1ra)  (100ng/ml),
providing  further  evidence  that  these  colonic  cells
possess a  functional  IL-1 receptor. Only  the second
peak was abolished when the cells were pretreated
with a selective COX-2 inhibitor L-745,337 (5-metha-
nesulfonamide-6-(2,4-difluorothiophenyl)-1-indanone,
a  generous  gift  from  Merck-Frosst  Center  for Ther-
apeutic Research, Canada12) before the addition of IL-
1, as shown in Fig. 8, providing additional evidence
that the second  peak  in PGE2 production is indeed
due to COX-2 induction.
Discussion
Cytokines play a vital role in coordinating inflamma-
tory responses. They are involved in responses to viral
and bacterial infections, immunity and hemopoiesis.
Various interleukins and  other cytokines have been
found to be widespread in their distribution and to
exert  different  effects  among  different  cell  popula-
tions. This complex network of regulatory factors may
be especially important in the mucosa of the gastro-
intestinal tract. Intestinal epithelial cells express and
respond to several active cytokines, including IL-1, IL-
2,  IL-6,  TNF-a ,  IFN-g and  TGF-b .13–17 The  gastro-
intestinal mucosal immune response system has been
recognized to encompass a diverse mixture of cells
within the mucosal lamina propria and gut associated
lymphoid  tissue,  whose  functional  properties  are
both mediated and modulated by a  highly complex
range of cytokines.
IL-1 has been shown to be a major constituent in
mucosal  inflammation.  Incubation  of  rabbit  colon
with  IL-1b induces  mucosal  production  of  PGE2,
PGF1a and  thromboxane.4 Cominelli  et  al.18 found
elevated  IL-1  levels  in  the  colon  of  rabbits  with
immune-complex-induced  colitis. The  levels  of  IL-1
correlated with the degree of inflammation. IL-1 also
regulates the rate of proliferation in keratinocytes,19
thymic epithelium20 and  fibroblasts,21,22 and  affects
intestinal  epithelial  cell  proliferation.  These  studies
suggest that IL-1 receptors are present on intestinal
epithelial cells and that IL-1 might act directly on the
intestinal  epithelium. IL-1R have been  shown  to be
present on IEC-18 rat intestinal epithelial cells23 and
on a human colon cancer cell line 24 which resembles
the type I IL-1 receptor. Similar findings were found in
the present study, where the IL-1 receptor, type I, was
identified on the colonic epithelial cell membranes.
Thus, the biological effects observed in the colonic
epithelial  cells  in  inflammation  are  due  to  the  IL-1
receptor type I, as has been suggested in other cell
types.25
Although it is true that in the inflamed intestine the
chief secretors of eicosanoids are likely to be infiltrat-
ing monocytes and/or macrophages and neutrophils,
the question  remains whether there is local prosta-
noid production by epithelial cells and whether that
production is regulated by agonists in the cell milieu.
We have shown  that IL-1b induces the synthesis of
PLAP in the rabbit distal colonic mucosa that in turn
activates PLA2 to result in increased levels of PGE2.6,8
In the present study, we were able to show that rabbit
colonic epithelial  cells also express functional  COX
and PLA2 enzyme, and are able to produce measurable
basal amounts of PGE2. PGE2 levels were significantly
increased when the cells were stimulated with IL-1b .
This increase is due to increases in the activity of the
IL-1 action and mechanism in epithelial cells
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FIG. 8. Levels of PGE2 in (d ) cells treated with IL-1b (10ng/ml) as compared with (s ) cells treated with the IL-1b and COX-2
synthesis inhibitor L-745,337. * P<0.05; P value represents the comparison of  the effect of IL-1b on PGE2 production as
compared with COX-2 inhibitor treated cells. Data are means±SE for four separate experiments.enzymes  involved  in  the  prostaglandin  metabolism
pathway, mainly PLA2 and/or COX.
Components of membrane phospholipids play an
important  role  in  cellular  signal  transduction. The
formation of certain lipid second messengers occurs
as the result of the PLA2-catalyzed cleavage of the fatty
acid from phospholipids. The released fatty acids may
regulate cellular functions themselves or, in the case
of arachidonic acid, may be metabolized to bioactive
prostaglandins and leukotrienes. These latter metabo-
lites govern cellular functions as diverse as inflamma-
tion, ion channel activities and neurotransmission.26
The release of arachidonic acid-derived lipid  media-
tors is a characteristic of chronic and acute inflamma-
tion. There are multiple PLA2 isoforms with varying
structural  and  functional  characteristics.  IL-1b has
been shown to specifically increase the activity of the
small  molecular  weight  PLA2 (of  group  II)  in  EL-4
murine  T  cells  without  any  effect  on  the  high
molecular weight enzyme.27 In our studies, we found
that IL-1b induced an increase in sPLA2 activity three-
to fivefold without affecting the cytoplasmic form of
the  enzyme  cPLA2. This  enhanced  enzyme  activity
induced  by  IL-1b is  due  to  the  increased  levels  of
PLAP  as  we  have  shown  recently,6,8 which  was
originally  isolated  by  its  antigenic  and  functional
similarities to melittin, a bee venom peptide.28
COX enzyme converts arachidonic acid to prosta-
glandins  and  thromboxanes.  COX  exists  in  at  least
two isoforms, a constitutive isoform, COX-1, and an
inducible form, COX-2. The COX isoforms are enco-
ded by genes located on different chromosomes29 and
are only 60% identical with the catalytic regions being
conserved.  COX-1  seems  to  represent  most  of  the
activity under basal conditions, while COX-2, which is
normally undetectable in most tissues, appears to be
the predominant isoform present under inflammatory
conditions. In the present study, IL-1b treatment had
no  effect  on  the  levels  of  COX-1,  but  induced  the
synthesis of COX-2 significantly. These IL-1b -induced
increases observed in PLA2 and COX-2 would there-
fore result in a large amount of prostaglandin produc-
tion. Interestingly, IL-1b caused a biphasic increase in
the levels of PGE2, where the first peak was reached
at  30min  and  correlated  well  with  the  increase  of
PLAP  levels and  PLA2 activity,  and the second  peak
reached at 6 h was completely due to the increase in
COX-2 levels.
In  summary,  cultured  colonic  epithelial  cells  iso-
lated from normal adult rabbits and grown in culture
possess  the  IL-1  receptor  and  all  the  machinery
necessary to produce prostanoids both constitutively
and in response to inflammatory stimuli. The presence
of IL-1 receptor on these epithelial cells suggests that
cytokines  might  regulate  epithelial  cell  function
directly, for example, to produce PGE2 in response to
inflammatory stimuli. This is the first study describing
the presence of IL-1 receptor in colonic epithelial cells
and describing the mechanism of action of how IL-1
can  directly  regulate  epithelial  cell  function.  The
biphasic increase in PGE2 levels seems to reflect the
different mechanisms by which IL-1 can affect epithe-
lial  cell  function  under  acute  or  under  chronic
conditions,  which  can  reflect  the  mechanisms
involved  in  acute  and  chronic  inflammation  in  the
intestine. The  acute  response  is  due  to  PLAP/PLA2
pathway  and  the  chronic  response  due  to  COX-2
pathway, both of which will lead to increases in PGE2.
ACKNOWLEDGEMENTS:  Funding  was  from  the  American  University  of
Beirut (University Research Board), from the Diana Tamari Sabbagh Founda-
tion  and  from  the Lebanese  National  Council for  Scientific Research. We
thank Dr J.S. Bomalaski for the antimelittin antibodies and Dr Holtsberg for
the PLAP probe, and thank Merck Frosst Center for Therapeutic Research,
Quebec, Canada for the COX-2 inhibitor L-745,337.
References
1. Bomsztyk K, Sims JE, Stanton TH, Slack J, McMahan CJ, Valentine MA,
Dower SK. Evidence for different interleukin 1 receptors in murine B-
and T-cell lines. Proc Natl Acad Sci USA 1989; 86: 8034–8038.
2. Sims JE, March CJ, Cosman D et al. cDNA expression cloning of the IL-1
receptor, a member of the immunoglobulin superfamily. Science 1988;
241: 585–589.
3. Sims JE, Acres RB, Grubin CE, McMahan CJ, Wignall JM, March CJ, Dower
SK. Cloning the interleukin receptor from human T cells. Proc Natl Acad
Sci USA 1989; 86: 8946–8950.
4. Cominelli F , Nast CC, Dinarello CA, Gentilini P, Zisper RD. Regulation of
eicosanoid production by rabbit colon in interleukin-1. Gastroenterolgy
1989; 97: 1400–1405.
5. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-b by
mononuclear cells isolated from mucosa with active ulcerative colitis of
Crohn’s disease. Gut 1989; 30: 835–838.
6. Homaidan FR, Desai H, Zhao L, Broutman G, Burakoff R. Regulation of
electrolyte transport with IL-1b in the  rabbit  distal  colon. Mediators
Inflammation 1995; 4: 61–66.
7. Homaidan  FR,  Zhao  LM,  Burakoff  R.  IL-1  induces  the  synthesis  of
phospholipase A2-activating protein in the distal colon. Gastroenterol-
ogy 1995; 108: A838.
8. Homaidan  FR,  Zhao  LM,  Burakoff  R.  IL-1  induces  the  synthesis  of
phospholipase A2-activating protein in the rabbit intestine. Am J Physiol
1997; 272: G1338–G1346.
9. LeDuc L, Brown L, Vidrich A. Bradykinin and FMLP stimulate prostanoid
production by adult rabbit colonocytes in culture. Am J Physiol 1994;
267: G778–G785.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 1970; 227: 680–685.
11. Young IT. Proof without prejudice: use of the Kolmogrov–Smirnov test
for the analysis of histograms from flow systems and other sources. J
Histochem Cytochem 1977; 25: 935–941.
12. Chan  CC,  Boyce  S,  Brideau  C  et  al.  Pharmacology  of  a  selective
cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflam-
matory agent with an ulcerogenic sparing effect in rat and nonhuman
primate stomach. J Pharmacol Exp Therapy 1995; 274: 1531–1537.
13. Chang EB,  Musch MW , Mayer L. Interleukins 1 and 3 stimulate anion
secretion in chicken intestine. Gastroenterolgy 1990; 98: 1518–1524.
14. Ciacci C, Mahida YR, Dignass A, Koizumi DM, Podolsky DK. Functional
interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 1993;
92: 527–532.
15. Madara  JL,  Stafford  J.  Interferon-g directly  affects  barrier  function  of
cultured  intestinal  epithelial  monolayers.  J  Clin  Invest 1989;  83:
724–727.
16. Shirota K, LeDuy L, Yuan SY, Jothy S. Interleukin-6 and its receptor are
expressed in human intestinal epithelial cells. Virchows Arch 1990; 58:
303–308.
17. Suemori S, Ciacci C, Podolsky DK. Regulation of transforming growth
factor expression in rat intestinal epithelial cell lines. J Clin Invest 1991;
87: 2216–2221.
18. Cominelli F , Nast CC, Clark BD et al. Interleukin 1 (IL-1) gene expression,
synthesis, and effect of specific IL-1 receptor blockade in rabbit immune
complex colitis. J Clin Invest 1990; 86: 972–980.
19. Mertz PM, Sauder DL, Davis SC, Kilian PL, Herron AJ, Eaglstein WH. IL-1
as a potent inducer of wound re-epithelization. Prog Clin Biol Res 1991;
365: 473–480.
20. Galy AH, Hadden EM, Touraine JL, Hadden JW. Effects of cytokines on
human thymic epithelial cells in culture, IL-1 induces thymic epithelial
cell proliferation and change in morphology. Cell Immunol 1989; 124:
13–27.
F. R. Homaidan et al.
196 Mediators of Inflammation · Vol 8 · 199921. Dukovich M, Severin JM, White SJ, Yamazaki S, Mizel SB. Stimulation of
fibroblast proliferation and prostaglandin production by purified recom-
binant murine interleukin 1. Clin Immunol Immunopathol 1986; 38:
381–389.
22. Elias JA, Lentz V . IL-1 and tumor necrosis factor synergistically stimulate
fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol
1990; 145: 161–166.
23. Sutherland DB, Varilek GW, Neil GA. Identification and characterization
of the rat intestinal epithelial cell (IEC-18) interleukin-1 receptor. Am J
Physiol 1994; 266: C1198–C1203.
24. Varilek GW, Neil GA, Bishop WP. Caco-2 cells express type I interleukin-1
receptor: ligand binding enhances proliferation. Am J Physiol 1994; 267:
G1101–G1107.
25. Sims  JE,  Gayle  MA,  Slack  JL  et  al.  Interleukin  1  signaling  occurs
exclusively via the type I receptor. Proc Natl Acad Sci USA 1993; 90:
6155–6159.
26. Pruzanski W, Vadas P . Phospholipase A2–a mediator between proximal and
distal effectors of inflammation. ImmunolToday1991; 12: 143–146.
27. Steiner MR, Bomalaski JS, Clark MA. Responses of purified phospholi-
pases A2 to  phospholipase A2 activating  protein  (PLAP) and  melittin.
Biochim Biophys Acta 1993; 1166: 124–130.
28. Clark MA, Conway TM, Shorr RGL, Crooke ST . Identification and isolation
of a mammalian protein which is antigenically and functionally related to
the phospholipase A2 stimulatory peptide melittin. J Biol Chem 1987;
262: 4402–4406.
29. Langenbach R, Morham SG, Tiano HF et al. Prostaglandin synthase 1 gene
disruption in mice reduces arachidonic acid-induced inflammation and
indomethacin-induced gastric ulceration. Cell 1995; 83: 483–492.
Received 11 June 1999;
accepted 2 August 1999
IL-1 action and mechanism in epithelial cells
Mediators of Inflammation · Vol 8 · 1999 197